Proactive Investors - Run By Investors For Investors

Auxly Cannabis acquires cannabis-focused Canadian research group KGK Science

KGK has expanded its research capabilities to include cannabinoid and animal products
Cannabis plants
Auxly Cannabis Group is a collective of entrepreneurs in the cannabis industry

Auxly Cannabis Group Inc (TSX-V:XLY) said on Tuesday it forged a share purchase agreement with KGK Science Inc to acquire all of its shares for US$12.3mln.

KGK is a leading health and wellness-focused private contract research organization based in London, Ontario. The company expects to leverage KGK’s expertise and research abilities to boost its product development efforts through collaboration with Auxly's wholly owned subsidiary, Dosecann Inc. 

For nearly two decades, KGK has served many of North America’s leading nutraceutical, natural health product and consumer packaged goods companies such as Kraft Foods, Sanofi, Nature’s Bounty, and NuSkin.

KGK works with their clients in substantiating claims for their products through randomized clinical trials in addition to providing other research services such as participant recruitment, regulatory compliance solutions, research support services and consulting.

Along with KGK’s involvement in the health and wellness space, KGK has expanded their research capabilities to include cannabinoid and animal products in recent years.

Auxly Cannabis Group is a collective of entrepreneurs in the cannabis industry. The company is based in Vancouver, Canada.

Its shares were recently up 2.3% to CC$0.89 in Toronto.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full XLY profile View Profile

Auxly Cannabis Group Inc Timeline

Related Articles

medical cannabis
September 30 2018
The companies will collaborate on activities to develop cannabinoid medicines as a medical option in Chile.
October 31 2018
The 35,000 sq ft automated facility is equipped with proprietary fertigation, operational and security systems
August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use